Form 4 for GH Guardant Health, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2024-12-31 · accession 0001576280-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-03 | 2024-12-31+ | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | +106.0K | 2.30M | +5% | $0 |
| DM | 2025-01-03 | 2024-12-31+ | GH | Talasaz AmirAli | Co-CEO, Dir | F - Tax | $30.55 | -49.1K | 2.21M | -2% | -$1.50M |
| DM | 2025-01-03 | 2024-12-31+ | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | -106.0K | 192.0K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | M | A | 11,462 | $0.00 | 2,215,894 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-01 | F | D | 43,309 | $30.55 | 2,261,331 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Common | Common Stock | 2024-12-31 | F | D | 5,809 | $30.55 | 2,210,085 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 4 | Common | Common Stock | 2025-01-01 | M | A | 94,555 | $0.00 | 2,304,640 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2024-12-31 | M | D | 11,462 | $0.00 | 0 | D | $0.00 · — to — | 11,462 Common Stock | (F2) This restricted stock unit award was granted on March 18, 2024 and vests in four equal installments on the last day of each calendar quarter, March 31st, June 30th, September 30th, and December 31st, 2024. (F3) Not applicable for Restricted Stock Units. |
| 6 | Derivative | Restricted Stock Units | 2025-01-01 | M | D | 94,555 | $0.00 | 191,978 | D | $0.00 · — to — | 94,555 Common Stock | (F4) This restricted stock unit award was granted on March 18, 2024 and vests with respect to 1/3 of the shares on January 1, 2025, and then quarterly for the remaining twenty-four months. (F3) Not applicable for Restricted Stock Units. |